Home
Resources
Product Analysis
Acknowledgements
About
Home
References
Market status
Market status
Under Development
Products 61 to 70 of 119
Modify Display Properties
Biotech components
Business models
Country of production
Country of distribution
Intended consumer
Date added
Date last modified
Known funding amount
Funding types
Industry
Market status
Organization
Organization type(s)
Product categories
Production process
Source
Trading symbol
Value chain stage
Sort: Title (A-Z)
Date added (oldest-newest)
Date added (newest-oldest)
Date modified (oldest-newest)
Date modified (newest-oldest)
Title (A-Z)
Title (Z-A)
Organization (A-Z)
Organization (Z-A)
Humanized Pig Organs
by
Synthetic Genomics
+
United Therapeutics’ Lung Biotechnology Inc
Biotech components:
Animal
Business models:
B2C
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Research
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/09/28 15:05 (6 years ago)
Known funding amount:
40,000,000 USD
Funding types:
Venture Capital
Industry:
Health
Market status:
Under Development
Organization type(s):
Private Company
Product categories:
Medical Treatment
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
N/A
Value chain stage:
Finished Product
Hydrogen Sulfide Sourced Fuels
by
Ginkgo Bioworks
Biotech components:
Bacteria
Business models:
B2B
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/10/02 11:54 (6 years ago)
Known funding amount:
6,438,793 USD
Funding types:
Government
Industry:
Energy
Market status:
Under Development
Organization type(s):
Private Company
Product categories:
Fuel and Energy
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
N/A
Value chain stage:
Finished Product
implanted device to control bladder function
by
Biotech components:
Animal
+
Molecule
Business models:
N/A
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2019/04/01 10:01 (5 years ago)
Date last modified:
2019/04/12 09:36 (5 years ago)
Known funding amount:
N/A
Funding types:
N/A
Industry:
Medical
Market status:
Under Development
+
More information needed
Organization type(s):
N/A
Product categories:
N/A
Production process:
N/A
Source:
Web search
Trading symbol:
N/A
Value chain stage:
Finished Product
Injectable Alpha 1-antitrypsin
by
Halozyme
Biotech components:
Enzyme
Business models:
B2C
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/08/30 11:49 (6 years ago)
Known funding amount:
200,000,000 USD
Funding types:
Shareholder Investment
Industry:
Health
Market status:
Under Development
Organization type(s):
Public Company
Product categories:
Medical Treatment
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
HALO
(NASDAQ)
Value chain stage:
Finished Product
Integriculture Cellular Meat
by
Integriculture Inc.
Biotech components:
Animal
Business models:
B2C
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2019/07/02 11:19 (5 years ago)
Date last modified:
2019/07/02 11:19 (5 years ago)
Known funding amount:
300,000,000
Funding types:
Venture Capital
Industry:
Food & Agriculture
Market status:
Under Development
Organization type(s):
Private Company
Product categories:
Food
Production process:
Open Release
Source:
Web search
Trading symbol:
N/A
Value chain stage:
Finished Product
INXN-3004: AML
by
Intrexon
Biotech components:
Virus
Business models:
B2B
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2020/02/10 09:59 (4 years ago)
Date last modified:
2020/02/10 09:59 (4 years ago)
Known funding amount:
N/A
Funding types:
Shareholder Investment
Industry:
Medical
Market status:
Under Development
Organization type(s):
Public Company
Product categories:
Medical Treatment
Production process:
N/A
Source:
Web search
Trading symbol:
XON
(NASDAQ)
Value chain stage:
Finished Product
Isobutene
by
Global Bioenergies
Biotech components:
Plant
Business models:
B2B
Country of production:
France
Country of distribution:
France
+
Netherlands
+
Germany
Intended consumer:
Consumer
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/08/30 11:49 (6 years ago)
Known funding amount:
23,000,000 EUR
Funding types:
Shareholder Investment
Industry:
Industrial
Market status:
Under Development
Organization type(s):
Public Company
Product categories:
Fuel and Energy
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
ALGBE
(EPA)
Value chain stage:
Input
L-Methionine
by
Metabolic Explorer SA
Biotech components:
Enzyme
Business models:
B2B
Country of production:
France
Country of distribution:
France
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/08/30 11:49 (6 years ago)
Known funding amount:
N/A
Funding types:
Shareholder Investment
Industry:
Food & Agriculture
Market status:
Under Development
Organization type(s):
Public Company
Product categories:
Feed
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
METEX
(EPA)
Value chain stage:
Input
Laundry Detergent Enzyme
by
Novozymes
Biotech components:
Enzyme
Business models:
B2B
Country of production:
Denmark
Country of distribution:
Denmark
+
China
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/10/08 14:50 (6 years ago)
Known funding amount:
12,880,000 DKK
Funding types:
Shareholder Investment
Industry:
Industrial
Market status:
Under Development
Organization type(s):
Public Company
Product categories:
Chemical
Production process:
Closed Production
Source:
Web search
Trading symbol:
NZYM-B
(CPH)
Value chain stage:
Input
Low Saturated Fat Canola Oil
by
Catalyxt
Biotech components:
Plant
Business models:
B2C
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/09/28 15:00 (6 years ago)
Known funding amount:
608,825,000 USD
Funding types:
Shareholder Investment
Industry:
Food & Agriculture
Market status:
Under Development
Organization type(s):
Public Company
Product categories:
Plant
Production process:
Open Release
Source:
Web search
Trading symbol:
CLXT
(NASDAQ)
Value chain stage:
Finished Product
1
…
3
4
5
6
7
8
9
10
11
…
12
Login
or
register
to add and edit products
Future
Bioengineered
Products
Home
Resources
Product Analysis
Acknowledgements
About
